Cargando…

A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks

BACKGROUND: Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of NPIs that may change according to disease prevalence and population response. Li...

Descripción completa

Detalles Bibliográficos
Autores principales: Skarp, Janetta E., Downey, Laura E., Ohrnberger, Julius W. E., Cilloni, Lucia, Hogan, Alexandra B., Sykes, Abagael L., Wang, Susannah S., Shah, Hiral Anil, Xiao, Mimi, Hauck, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192223/
https://www.ncbi.nlm.nih.gov/pubmed/34114184
http://dx.doi.org/10.1007/s40258-021-00659-z
_version_ 1783706014729633792
author Skarp, Janetta E.
Downey, Laura E.
Ohrnberger, Julius W. E.
Cilloni, Lucia
Hogan, Alexandra B.
Sykes, Abagael L.
Wang, Susannah S.
Shah, Hiral Anil
Xiao, Mimi
Hauck, Katharina
author_facet Skarp, Janetta E.
Downey, Laura E.
Ohrnberger, Julius W. E.
Cilloni, Lucia
Hogan, Alexandra B.
Sykes, Abagael L.
Wang, Susannah S.
Shah, Hiral Anil
Xiao, Mimi
Hauck, Katharina
author_sort Skarp, Janetta E.
collection PubMed
description BACKGROUND: Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of NPIs that may change according to disease prevalence and population response. Little is known with regard to how costly each NPI is to implement. This information is essential to inform policy decisions for outbreak response. OBJECTIVE: To address this gap in existing literature, we conducted a systematic review on outbreak costings and simulation studies related to a number of NPI strategies, including isolating infected individuals, contact tracing and quarantine, and school closures. METHODS: Our search covered the MEDLINE and EMBASE databases, studies published between 1990 and 24 March 2020 were included. We included studies containing cost data for our NPIs of interest in pandemic, epidemic, and outbreak response scenarios. RESULTS: We identified 61 relevant studies. There was substantial heterogeneity in the cost components recorded for NPIs in outbreak costing studies. The direct costs of NPIs for which costing studies existed also ranged widely: isolating infected individuals per case: US$141.18 to US$1042.68 (2020 values), tracing and quarantine of contacts per contact: US$40.73 to US$93.59, social distancing: US$33.76 to US$167.92, personal protection and hygiene: US$0.15 to US$895.60. CONCLUSION: While there are gaps and heterogeneity in available cost data, the findings of this review and the collated cost database serve as an important resource for evidence-based decision-making for estimating costs pertaining to NPI implementation in future outbreak response policies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-021-00659-z.
format Online
Article
Text
id pubmed-8192223
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81922232021-06-11 A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks Skarp, Janetta E. Downey, Laura E. Ohrnberger, Julius W. E. Cilloni, Lucia Hogan, Alexandra B. Sykes, Abagael L. Wang, Susannah S. Shah, Hiral Anil Xiao, Mimi Hauck, Katharina Appl Health Econ Health Policy Systematic Review BACKGROUND: Non-pharmaceutical interventions (NPIs) are the cornerstone of infectious disease outbreak response in the absence of effective pharmaceutical interventions. Outbreak strategies often involve combinations of NPIs that may change according to disease prevalence and population response. Little is known with regard to how costly each NPI is to implement. This information is essential to inform policy decisions for outbreak response. OBJECTIVE: To address this gap in existing literature, we conducted a systematic review on outbreak costings and simulation studies related to a number of NPI strategies, including isolating infected individuals, contact tracing and quarantine, and school closures. METHODS: Our search covered the MEDLINE and EMBASE databases, studies published between 1990 and 24 March 2020 were included. We included studies containing cost data for our NPIs of interest in pandemic, epidemic, and outbreak response scenarios. RESULTS: We identified 61 relevant studies. There was substantial heterogeneity in the cost components recorded for NPIs in outbreak costing studies. The direct costs of NPIs for which costing studies existed also ranged widely: isolating infected individuals per case: US$141.18 to US$1042.68 (2020 values), tracing and quarantine of contacts per contact: US$40.73 to US$93.59, social distancing: US$33.76 to US$167.92, personal protection and hygiene: US$0.15 to US$895.60. CONCLUSION: While there are gaps and heterogeneity in available cost data, the findings of this review and the collated cost database serve as an important resource for evidence-based decision-making for estimating costs pertaining to NPI implementation in future outbreak response policies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40258-021-00659-z. Springer International Publishing 2021-06-11 2021 /pmc/articles/PMC8192223/ /pubmed/34114184 http://dx.doi.org/10.1007/s40258-021-00659-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Systematic Review
Skarp, Janetta E.
Downey, Laura E.
Ohrnberger, Julius W. E.
Cilloni, Lucia
Hogan, Alexandra B.
Sykes, Abagael L.
Wang, Susannah S.
Shah, Hiral Anil
Xiao, Mimi
Hauck, Katharina
A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
title A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
title_full A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
title_fullStr A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
title_full_unstemmed A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
title_short A Systematic Review of the Costs Relating to Non-pharmaceutical Interventions Against Infectious Disease Outbreaks
title_sort systematic review of the costs relating to non-pharmaceutical interventions against infectious disease outbreaks
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192223/
https://www.ncbi.nlm.nih.gov/pubmed/34114184
http://dx.doi.org/10.1007/s40258-021-00659-z
work_keys_str_mv AT skarpjanettae asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT downeylaurae asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT ohrnbergerjuliuswe asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT cillonilucia asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT hoganalexandrab asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT sykesabagaell asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT wangsusannahs asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT shahhiralanil asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT xiaomimi asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT hauckkatharina asystematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT skarpjanettae systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT downeylaurae systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT ohrnbergerjuliuswe systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT cillonilucia systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT hoganalexandrab systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT sykesabagaell systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT wangsusannahs systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT shahhiralanil systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT xiaomimi systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks
AT hauckkatharina systematicreviewofthecostsrelatingtononpharmaceuticalinterventionsagainstinfectiousdiseaseoutbreaks